Vicki Sato resigns from Galapagos Board
(Thomson Reuters ONE) -
Mechelen, Belgium; 9 January 2015 - Galapagos NV (Euronext: GLPG) announces the
resignation of Dr Vicki Sato as a member of its Board of Directors, effective
31 December 2014.
Dr Sato has been a member of the Galapagos Board since 2011. She is also a
member of the Bristol-Myers Squibb Board of Directors. Dr Sato is leaving the
Board of Galapagos to avoid any potential conflicts of interest.
"We wish to thank Vicki for her strong contribution to the evolution of
Galapagos into a full-fledged, mature therapeutic pipeline company," said Dr Raj
Parekh, Chairman of the Board of Directors of Galapagos. "We wish Vicki much
success going forward."
About Galapagos
Galapagos (Euronext: GLPG; OTC: GLPYY) is specialized in novel modes-of-action,
with a large pipeline comprising three Phase 2 programs, two Phase 1 studies,
five pre-clinical, and 25 discovery small-molecule and antibody programs in
cystic fibrosis, inflammation, antibiotics, metabolic disease, and other
indications. In the field of inflammation, AbbVie and Galapagos signed an
agreement for the development and commercialization of GLPG0634. GLPG0634 is an
orally-available, selective inhibitor of JAK1 for the treatment of rheumatoid
arthritis and potentially other inflammatory diseases, currently in Phase 2B
studies in RA and in Phase 2 in Crohn's disease. Galapagos has another
selective JAK1 inhibitor, GSK2586184 (formerly GLPG0778, in-licensed by
GlaxoSmithKline in 2012). GLPG1205, a first-in-class inhibitor of GPR84, is
currently being tested in a Phase 2 Proof-of-Concept study in ulcerative colitis
patients. GLPG1690 is a first-in-class compound that targets pulmonary diseases
and is currently in a Phase 1 study. AbbVie and Galapagos signed an agreement
in cystic fibrosis to develop and commercialize molecules that address mutations
in the CFTR gene. Potentiator GLPG1837 started Phase 1 last month, and
corrector GLPG2222 is at the pre-clinical candidate stage. The Galapagos Group,
including fee-for-service subsidiary Fidelta, has around 400 employees,
operating from its Mechelen, Belgium headquarters and facilities in The
Netherlands, France, and Croatia. Further information at: www.glpg.com
CONTACT
Galapagos NV
Elizabeth Goodwin, Head of Corporate Communications & IR
Tel: +31 6 2291 6240
ir(at)glpg.com
Galapagos forward-looking statements
This release may contain forward-looking statements, including, without
limitation, statements containing the words "believes," "anticipates,"
"expects," "intends," "plans," "seeks," "estimates," "may," "will," "could,"
"stands to," and "continues," as well as similar expressions. Such forward-
looking statements may involve known and unknown risks, uncertainties and other
factors which might cause the actual results, financial condition, performance
or achievements of Galapagos, or industry results, to be materially different
from any historic or future results, financial conditions, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, the reader is advised not to place any undue reliance on
such forward-looking statements. These forward-looking statements speak only as
of the date of publication of this document. Galapagos expressly disclaims any
obligation to update any such forward-looking statements in this document to
reflect any change in its expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is based, unless
required by law or regulation.
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Galapagos NV via GlobeNewswire
[HUG#1885420]
Unternehmensinformation / Kurzprofil:
Datum: 09.01.2015 - 07:30 Uhr
Sprache: Deutsch
News-ID 363337
Anzahl Zeichen: 4562
contact information:
Town:
Mechelen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Vicki Sato resigns from Galapagos Board"
steht unter der journalistisch-redaktionellen Verantwortung von
Galapagos NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
